Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at conflicts@propublica.org. Read more below.
George Georgiou
Boston Children's Hospital, Department: Na
Should you be removed from our database? Contact us at conflicts@propublica.org. Read more below.
Orros Biotherapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
See attached report
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
Narrative A central issue in research on vaccines for both influenza virus and HIV is to selectively elicit antibodies that recognize conserved sites ('epitopes') on the viral glycoprotein. For influenza virus, frequent mismatches of vaccine and circulating strains make a 'universal' flu vaccine an important public-health target, quite apart from the organizational and economic challenges of an annual vaccination effort. This project will generate and then apply the understanding needed for a systematic approach to designing such a vaccine.
Filed on September 28, 2018.
Tell us what you know about George Georgiou's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “George Georgiou”
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeConflict of Interest | CompanyAeglea, LLC. | Disclosed ValueValue cannot be readily determined |
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeConflict of Interest | CompanyOrros Biotherapeutics, LLC | Disclosed ValueValue cannot be readily determined |
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeConflict of Interest | CompanyAeglea Biotherapeutics | Disclosed Value>$600,000 |
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeFinancial Disclosure | CompanyAeglea Biotherapeutics, LLC | Disclosed Value |
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeConflict of Interest | CompanyAeglea Biotherapeutics | Disclosed Value$0 - $4,999 |
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeConflict of Interest | CompanyGMA, LLC | Disclosed ValueValue cannot be readily determined |
NameGeorge Georgiou | InstitutionUniversity of Texas, Austin | TypeConflict of Interest | CompanyAeglea, LLC. | Disclosed ValueValue cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.